For decades, biomass residuals like sawdust and husks were dismissed as “low-value” waste, while bioplastics were sidelined as a niche curiosity. Today, a massive paradigm shift is quietly outpacing global policy and sustainability targets—transforming how materials are sourced, produced, and reimagined across industries, including healthcare.
This session explores the convergence of raw biomass and advanced biotechnology to reveal a future where materials are grown, not just manufactured. In healthcare—one of the most resource-intensive sectors—this shift is already underway. Companies like Ambu are translating these innovations into practice by integrating bio-based materials into single-use medical devices, demonstrating that high-performance, patient-safe products can also reduce reliance on fossil-based plastics.
Join industry leaders from Lignetics, CJ Biomaterials, and Ambu as they challenge conventional thinking around bio-based materials. Together, we will trace the journey from foundational market shifts to the cutting edge of fermentation technology—where bacteria and yeast transform organic residuals into high-performance fibers and bioplastics at scale. We’ll also explore how these materials are being applied in highly regulated sectors, offering real-world insight into what it takes to move from innovation to adoption.
Participants will gain a clearer understanding of the “perceived vs. possible” gap in manufacturing, the rapid acceleration of fermentation scale, and how the underlying logic of this bio-revolution applies across industries—from packaging to energy to medical technology. Ambu will provide a healthcare lens, sharing how bio-based innovation is enabling more sustainable product design today while laying the groundwork for circularity and material recovery in the future.
The future of manufacturing isn’t coming—it’s already being brewed, scaled, and implemented.